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Abstract
Background: The mounting evidence linking hypothyroidism during pregnancy with poor pregnancy outcome
underscores the need for screening and, therefore, a search for more reliable and cheaper screening methods.
Methods: The study was conducted in two phases. The phase one study comprised of healthy women in different
stages of pregnancy who attended routine antenatal clinic at St Theresa’s Maternity Hospital, Enugu, Nigeria from
September 6 to October 18 1994. In this study the variables compared between the hypothyroid and non-
hypothyroid pregnant women were maternal age, the number of the pregnancy or gravidity, gestational age,
social class, body weight, height, the clinically assessed size of the thyroid gland, serum free thyroxin (FT4) and
serum thyrotrophin (TSH). Based on the parameter differences between the two comparison groups of pregnant
women two Logistic models, Model I and Model 11, were derived to differentiate the hypothyroid group from
their non-hypothyroid counterparts. The two logistic models were then applied in a prospective validation study
involving 197 pregnant women seen at presentation in Mother of Christ Specialist Hospital and Maternity, Ogui
Road, Enugu from March 2002 to November 2007
Findings: The findings were that 82 (50.3%) of the 163 pregnant women had thyroid gland enlargement while 60
(36.8%) had hypothyroidism as defined by FT4 values below and/or TSH above their laboratory reference ranges.
The pregnant subjects with hypothyroidism, compared with their non-hypothyroid counterparts, were
characterized by a higher gravidity (p < 0.01), a higher body weight (p < 0.01), a higher goiter prevalence rate (p <
0.01) and a more advanced gestational age (p < 0.0001). A significant, positive correlation was also found between
body weight and gestational age (r = 0.5; p < 0.01) At the cut-off point for Model l (fitted with gravidity, thyroid
size and gestational age) it had a sensitivity of 100%, a specificity of 72.8% and an overall predictive accuracy of
82.9%; whereas for Model II (fitted with gravidity, thyroid size and body weight) the sensitivity was 100%, the
specificity was 59.2% and the overall accuracy of discrimination was 74.8%. In the prospective validation study both
models showed a sensitivity of 100% each with specificities of 85.5% for Model I and 76.2% for Model II.
Conclusion: It is concluded that logistic models fitting gravidity, thyroid gland size and gestational age or body
weight are useful alternatives in screening for hypothyroidism during pregnancy. There is, however, a need for
further independent confirmation of these findings.
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Introduction
An estimated two billion individuals worldwide have
insufficient iodine intake, with those in south Asia and
sub-Saharan Africa particularly affected [1]. Iodine defi-
ciency has many adverse effects on growth and develop-
ment. These effects are due to inadequate production of
thyroid hormones and are termed iodine-deficiency dis-
orders. Iodine deficiency is the commonest cause of pre-
ventable mental impairment worldwide [2]. Iodine
deficiency disorders (IDD) also include various degrees
of thyroid gland enlargement and thyroid hypofunction.
Pregnancy constitutes an increased stress on the thyroid
gland, reflecting an increased demand on the maternal
thyroid hormone production to meet both fetal and * Correspondence: drtonymbah58@yahoo.com
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original work is properly cited.maternal needs. Pregnancy is, therefore, an aggravating
factor for IDD [3,4]. There is increasing evidence that
even mild degrees of hypothyroidism during pregnancy,
if not treated, is associated with poor outcome of the
gestation, including fetal neuro-intellectual underdeve-
lopment which manifests as varying degrees of learning
disabilities later in life [5-7]. In many developing coun-
tries where IDD is still a public health problem the
overall negative impact on national development is
incalculable [8].
Although there may be little difficulty in recognizing
clinically overt hypothyroidism in pregnancy, the same
cannot be said of sub-clinical hypothyroidism and
hypothyroxinaemia, both types of which have also been
associated with fetal neuro-intellectual underdevelop-
ment [6,7]. The latter can only be detected with the
expensive and technically sophisticated hormonal assay
techniques as are currently available for the assessment
of thyroid function. These hormonal assay methods are
certainly not cost-effective for use in entire population
screenings, especially in IDD-affected countries that may
have been already impoverished from the effect of the
IDD itself [8,9].
The foregoing has made it more urgent to search for
easier and cheaper alternative methods adaptable for
population screening of pregnant women for various
degrees of hypothyroidism. The interrelationships
observed in the initial study between key gestational
variables and the chemical status of thyroid function in
pregnancy provided a veritable tool for the formulation
and testing of the hypothesis that gestation-related clini-
cal variables are useful in the prediction of gestational
hypothyroidism.
Methods
The Ethics Committee of University of Nigeria Teaching
Hospital (UNTH), Enugu, approved this study prior to
its take-off. All the pregnant women who attended rou-
tine antenatal clinic at Saint Theresa’s Maternity Hospi-
tal in Enugu, Nigeria from September 6 to October 18,
1994 and who gave informed consent were screened for
eligibility to participate in the initial study. This was
done using an entrance checklist designed to exclude
persons with evident concomitant acute or chronic ill-
nesses and those using drugs known to independently
alter the thyroid function or affect the assay results
[10,11]. Out of the 222 pregnant women seen during
the study period, 163 satisfied the inclusion criteria and
so were used for the current analyses. The study hospi-
tal runs a busy general obstetrics practice and so was
chosen partly to avoid referral bias. Each subject was
studied once during which the age, the gestational age,
the number of the pregnancy or gravidity, the social
class (scored 1-5 for the highest class-the lowest class).
The scores were obtained by averaging each patient’s
two other scores; one for education and the other for
occupation using the system developed by Oyedeji and
described in detail elsewhere [12]. The height and the
body weight were documented. The gestational age of
the subjects was calculated from the last menstrual per-
i o d( L . M . P . )a n d / o rd e t e r m i n e db ym e a s u r e m e n to ft h e
symphysio-fundal height where the L.M.P was indeter-
minate, as is done conventionally. The size of the thyr-
oid gland was assessed clinically and classified by size
into 0, IA, IB, 2 and 3 using World Health Organiza-
tion’s( W . H . O ’s) recommended criteria [1]. One of the
authors (AUM) carried out all the thyroid examinations
and did the goiter classifications. A single 5 ml venous
blood sample was also taken from each of the partici-
pants for serum free thyroxine and serum thyrotrophin
assays. A prior decision was to define hypothyroidism as
FT4 below the laboratory reference range of 9.5-23.6
pmo1/L and/or TSH above the laboratory reference
range of 0.5-6.0 mU/L. All the assays were run in dupli-
cates. FT4 was determined using commercial kits that
employ magnetic solid phase separation and enzyme
immunoassay methods (Serrano Diagnostics, Coinsins,
Switzerland). TSH assays were carried out using the
two-step immunoradiometric assay (IRMA) with bulk
reagents from NETRIA of London, England. The lower
detection limits for FT4 and TSH were 0.06 pmoI/L and
0.01 mU/L respectively, while the intra-assay and
inter¬-assay coefficients of variation were both ≤ 6.4%.
Prospective validation
In a limited prospective validation study all the pregnant
volunteers who gave informed consent participated in
the study. They were recruited at booking from Mother
of Christ Specialist Hospital and Maternity, Ogui Road,
Enugu from March 2002 to November 2007. The gesta-
tional age, gravidity, body weight, thyroid size, TSH and
FT4 values were determined using the same methods
and techniques as already described in the initial study.
The data entry and analysis were done at the end of the
study, as was decided upon prior to the onset of the
validation study.
Statistical analysis
The statistical analysis was performed using the Statisti-
cal Package for the Social Sciences version 13 (SPSS-13)
[13] run on a compatible personal computer. The data
collected in the initial study were all examined for distri-
butional patterns, at first visually using quantal-¬quantal
plots and then confirmed at p > 0.05 using the Shapiro-
Wilk Normality test. Subsequently, the data were com-
pared between the hypothyroid and the non-¬hypothyr-
oid pregnant women employing parametric t-tests and
non-parametric Mann-Whitney U tests as appropriate
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tively. The Chi-square test was used to analyze binary
data. Correlation coefficients and their levels of statisti-
cal significance were determined using simple linear
regressions and the Spearman’s non-parametric assess-
ment of co-linearity. The level accepted as statistically
significant was if p < 0.05. The use of discriminant ana-
lyses in providing solutions to problems involving classi-
fication into groups has been extensively reviewed
[14,15]. Multivariate linear models, although very sim-
ple, were considered inappropriate in this case because
of the variegated nature of our data [14]; continuous,
d i s c r e t ea n db i n a r yd a t aw e r ef i t t e dt o g e t h e ri no n e
model.
Multivariate logistic analyses were performed in
which the variables entered were those that differed
significantly between the two comparison groups. For
the purpose of the logistic regression analyses the thyr-
oid size was recorded as follows: (i) gland not visible
when the neck is in the normal position (grades 0, IA
and IB according to the World Health Organization’s
classification) = 1, (ii) gland visible when the neck is in
the normal position (grades 2 and 3 according to the
World Health Organization’s classification) = 2. This
modification was done solely for computational
convenience.
The fitted models belong to the binomial family of
the Generalized Linear Models [15] with the Logit link
function. These models are based on the general
assumption that ln[p(H)/(1-p(H)] = a+b1x1+b2x2
+b3x3...+bnxn; where ln is the Naperian logarithm, p(H)
is the predicted probability for chemical hypothyroid-
ism, a+b1x1 +b2x2 +b3x3+bnxn is the linear predictor
of the logistic regression function in which a is the
intercept, b1, b2, b3...bn are the coefficients and x1, x2,
x3...xn are the predictor variables. Transforming the
same basic equation gives p(H) = e
bx1(1+e
bx); where
bx is the linear predictor a+b1x1+b2x2+b3x3...+bnxn.
and e is the base of the Naperian logarithm. Gesta-
tional age and body weight were significantly corre-
l a t e da n d ,a sar u l e ,b o t hs h o u l dn o tb ee n t e r e di nt h e
same model [15]. Two alternative models (Model I and
Model II) were, therefore, derived. The variables
entered in Model I were gravidity, goitre score and
gestational age; whereas in Model II the variables were
gravidity, goitre score and body weight. The variables
were fitted using the Maximum Likelihood method
[15]. Receiver Operating Characteristics (ROC) data
generated for each of the two models (performances at
each of the predicted probability levels for the patients
with hypothyroidism) were used to construct ROC
curves whose slopes and area under the curves (AUCs)
were further compared for statistical significance.
Analysis of the prospective validation data
Using the MLAB Mathematical and Statistical Modeling
package [15] the p(H) for each subject was calculated
automatically after imputing into the computer Gravid-
ity, Goiter score and Gestational age for Model I; and
Gravidity, Goiter score and Body weight for Model II.
Subjects with p(H) values compatible with hypothyroid-
ism were then identified using the already established
cut-off values for each of the two models. The chemical
indices of hypothyroidism found among the subjects
were then compared against the individual’s predicted
probability of hypothyroidism, p(H). The accuracy of the
predictions was used in assessing the performance of
each of the two logistic models. The criteria used to
define hypothyroidism in the validation study were the
same as those used in the initial study.
Results
Results are stated as Mean ± Standard error of the mean
(SEM) for normally distributed data; Minimum-Maxi-
mum range (median) for non-normal as well as catego-
rical data; and percent (%) for binary data. In the initial
study the 163 subjects were aged 29.9 ± 0.8 years (mean
± SEM), their mean gestational age was 28.4 ± 0.6
weeks, their range of gravidity was l-8 (median = 3),
their range of scores for social class was 1-5 (median =
4), their height ranged 1.40 m-¬1.90 m (median = 1.60
m) while their mean body weight was 75.2 ± I.4 kg. The
overall goiter prevalence rate found among the patients
was 50.3%. The observed range of FT4 was 5.4-26.1
pmol/L (median = 13.8 pmol/L) while that for TSH was
0.0-10.6 mU/L (median = 4.9 mU/L). The laboratory
reference ranges for these parameters were 0.5-6.0 mU/
L for the TSH and 9.5-23.6 pmo1/L for the FT4. Out of
all the participants in the initial study 60 (36.8%) met
t h ed i a g n o s t i cc r i t e r i af o rh y p o t h y r o i d i s m .O u to ft h i s
number 47 or 78.3% had sub-clinical hypothyroidism
(high TSH with normal FT4), 12 or 20% had hypothyr-
oxinaemia (normal TSH with low FT4) while only one
patient had overt hypothyroidism (high TSH with low
FT4). In (table 1), the demographic data and total goiter
prevalence rates were compared between those with
hypothyroidism and their non¬-hypothyroid counter-
parts. It was found that the subjects with hypothyroid-
ism were significantly older (p < 0.01), had a higher
gravidity (p < 0.001), weighed more (p < 0.001), were
more goitrous (p < 0.01) and were at a more advanced
gestational age (p < 0.001). The relationship between
age and gravidity as well as between gestational age and
body weight was further investigated using Spearman’s
and simple linear regression correlation coefficients
respectively. Whereas the coefficient of correlation
between gestational age and body weight was statistically
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idity was not (r = 0.06; P > 0.05).
The logistic regression results
In model I the variables entered were age, gravidity, goi-
ter score and gestational age; while in model II they
were age, gravidity, goiter score and body weight. The
final models (I and II) did not include age since the
removal of this variable did not affect the deviance of
either model significantly (c
2 = 1.759; df = 1; P > 0.05
for model I and c
2 = 2.550; df = 1; p > 0.05 for model
II). The predicted probability of hypothyroidism, p(H),
was determined for each of the pregnant women in con-
formity with the general logistic function: p(H) = e
bx/(1
+e
bx). Tables 2 and 3 show the coefficients of the logis-
tic regressions, with their standard errors and levels of
statistical significance, for Models I and II respectively.
When the regression coefficients for model I were sub-
stituted in the linear predictor its value was determined
by: bx = -2.1001 + 0.0286 × GRAVIDITY + 0.0717 ×
GOITRE SCORE + 0.0413 × GEST.AGE (in weeks.). For
model II also bx = -3.6496 + 0.2661 × GRAVIDITY +
0.4063 × GOITRE SCORE + 0.0124 × WEIGHT (in
kilogrammes). Figures 1 and 2 show respectively plots of
predicted probabilities, p(H), against the serial number
of each patient for Models I and II. There were evi-
dently more false-positive scores with Model II than
with Model I. The Receiver-Operator Characteristics
(ROC) curves for the two models are shown superim-
posed in Figure 2. An analysis of the two Receiver-
Operator Characteristics (ROC) curves showed a left-
shift position for Model I, an indication of its better per-
formance compared with Model II. Although the ROC
curve for Model I showed a steeper slope compared
with that of model II (p < 0.001), there was, however, an
insignificant difference in the area under the curves
(AUCs) for both models (95% Confidence interval =
-0.029 to 0.457, p > 0.05). The optimal cut-off point of
the probability for model I which gave 100% sensitivity
was 0.18. At that point its specificity and overall accu-
racy of discrimination were 74.8% and 82.9% respec-
tively. For model II the optimal specificity achieved at
100% sensitivity was 64.1% and this occurred at the cut-
Table 1 A comparison of the demographic and goitre data between the hypothyroid and non-hypothyroid pregnant
women in the initial study.
Parameter Subjects Without Hypothyroidism (N = 103) Subjects With Hypothyroidism (N = 60) P-Value
Age (Yrs) 22.9 ± 0.6 25.4 ± 0.7 < 0.01
#*
Gest. Age (Wks) 23.8 (4.3-33.1) 29.6(16.8-40.1) < 0.001
+*
Social Class (Scores) 4(1-5) 4(1-5) > 0.05
+ns
Gravidity 3(1-8) 2(1-6) < 0.01
+*
Weight (Kg) 63.5(51.3-93.7) 71.0(48.9-102.7) < 0.01
+*
Height (m) 1.6 ± 0.02 1.6 ± 0.03 > 0.05
#ns
Goiter Frequency (%) 43(71.7%) 39(37.9%) < 0.01
$*
N = Number of patients
* = Statistically significant at p < 0.05.
ns = Not statistically significant at p < 0.05
# = Analysis by two-tailed, unpaired Student t-test.
+ = Analysis by Mann-Whitney U test
$ = Analysis by Chi-square test
Yrs = Years
Wks = Weeks
Table 2 The coefficients of the logistic regressions for
model I
Coefficients Values Standard Errors P-Values
Gravidity 0.0286 0.0104 < 0.05*
Goiter Score (1-2) 0.0717 0.0118 < 0.05*
Gest. Age (Wks) 0.0413 0.0027 < 0.001*
Intercept -2.2001 0.0606 < 0.001*
* = Statistically significant at p < 0.05
Goiter Scores: 1 = Goiter palpable but invisible with neck in the normal
position; 2 = Goiter visible with neck in the normal position
Wks = Weeks
Table 3 The coefficients of the logistic regressions for
model II
Coefficients Values Standard Errors P-Values
Gravidity 0.2661 0.1661 < 0.05*
Goiter Score (1-2) 0.4063 0.1064 < 0.05*
Weight (Kg) 0.0124 0.0192 < 0.001*
Intercept -3.6496 1.1032 < 0.001*
* = Statistically significant at p < 0.05
Goiter Scores: 1 = Goiter palpable but invisible with neck in the normal
position; 2 = Goiter visible with neck in the normal position
Wks = Weeks
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Figure 1 The predicted probability scores for hypothyroidism, p(H), in the initial study. The plots show the predicted probability scores
plotted against the serial number of each patient for those with hypothyroidism (■) and those without hypothyroidism (□), using model I (A)
and using model II (B). The lines parallel to the x-axes show the respective cut-off points for Model I (0.18) and for Model II (0.20). For purposes
of clarity, the patients were numbered after sorting them in the descending order of their TSH values.
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Page 5 of 10off point of 0.20 where it achieved an overall discrimina-
tion accuracy of 74.8%.
The results of the prospective validation study
A total of 197 pregnant women participated in this pro-
spective validation study. Their mean age was 23.8 ± 1.3
years, their mean gestational age was 22.5 ± 0.9 weeks
and their mean body weight was 53.7 ± 1.7 kg. Their
gravidity in minimum-maximum range(Median) was 1-5
(1.87). Goiter was prevalent in 18 (9.13%). The largest
goiter size encountered was stage IB (W.H.O. Classifica-
tion). The TSH was 1.8 mU/L-6.9 mU/L(4.0 mU/L)
while the FT4 was 7.9 pmol/L-28.2 pmol/L(16.85 pmol/
L). Out of the 197 pregnant women in this study 12
(6.09%) actually had hypothyroidism as defined by the
afore-mentioned criteria. Table 4 shows a comparison of
the most relevant demographic and thyroid function
data between the subjects in the initial study and those
in the validation study. With reference to these para-
meters the two groups were found to differ significantly,
with those in the initial study being much older (p <
0.001), having more advanced gestational age (p <
0.0001) and weighing much more (p < 0.0001). The sub-
jects in the initial study were also found to have had
more pregnancies (p < 0.001) and had a greater fre-
quency and size of thyroid gland enlargement or goiter
(p < 0.0001). Interestingly, the subjects in the initial
study were also characterized by a higher TSH and a
lower FT4 when compared with those in the validation
study (p < 0.001 and p < 0.0001 respectively).
Figures 3A and 3B display graphically the perfor-
mances of Model I and Model II respectively. It was
found that both models correctly identified all those
that had hypothyroidism, thereby giving a sensitivity of
100% for each model and specificities of 85.5% and
76.2% for Models I and II respectively.
Discussion
Our initial study showed a 36.8% prevalence of
hypothyroidism among the pregnant women studied.
This prevalence level of hypothyroidism is not uncom-
mon in an environment like Nigeria where iodine defi-
ciency disorders (IDD) are still of public health concern
[1-4,16]. In areas of Nigeria with IDD problem the pre-
valence rates of goiter reported during pregnancy range
Figure 2 The receiver operating characteristics (ROC) curves for
models I and II in the initial study. The receiver operating
characteristics (ROC) curve for model I is indicated by crosses (+++
+) while that for model II is indicated by broken lines (——). The
ROC data used was generated by determining the sensitivities and
specificities of each model at different cut-off points of the
predicted probability scores of the patients with hypothyroidism.
Table 4 A comparison of the demographic, goiter and thyroid function data between the pregnant women in the
initial study and those in the validation study.
PARAMETER (Unit) INITIAL STUDY VALUE:
N = 163
VALIDATION STUDY VALUE:
N = 197
P-Value
Age (Yrs) 29.9 ± 0.8 23.8 ± 1.3 < 0.001
#*
Gestational Age (Wks) 28.4 ± 0.6 22.5 ± 0.9 < 0.0001
#*
Gravidity 3.0(1-8) 1.9(1-5) < 0.001
+*
Goiter Prevalence Rate (%) 50.3 9.1 < 0.0001
$*
Body Weight (Kg) 75.2 ± 1.4 53.7 ± 1.7 < 0.0001
#*
TSH (mU/L) 4.9(00-10.6) 4.0(1.8-6.9) < 0.001
+*
FT4 (pmol/L) 13.8(5.4-26.1) 16.9(7.9-28.2) < 0.0001
+*
N = Number of subjects
* = Statistically significant at p < 0.05
# = Analysis by two-tailed, unpaired Student t-test
+ = Analysis by Mann-Whitney U test
$ = Analysis by Chi-square test
Yrs = Years
Wks = Weeks
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Figure 3 The predicted probability scores for hypothyroidism, p(H), in the validation study. The plots show the predicted probability
scores plotted against the serial number of each patient for those with hypothyroidism (■) and those without hypothyroidism (□), using model I
(A) and using model II (B). The lines parallel to the x-axes show the respective cut-off points for Model I (0.18) and for Model II (0.20). For
purposes of clarity, the patients were numbered after sorting them in the descending order of their TSH values.
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Page 7 of 10from 46.8% to 92.7% [16-18]. The goiter prevalence rate
of 50.4% found in this study is, therefore, within the
range reported in the previous studies. The genesis of
endemic goiter in the Eastern part of Nigeria has been
traced to a number of staple foods common in this area,
in addition to the age-long method of preserving salt
over the fire place, thereby depleting the iodine content
[19-21]. Although iodine deficiency causes hypothyroid-
ism generally it is more so during pregnancy when the
requirement for thyroid hormones is increased with a
parallel decrease in the maternal iodine pool [22]. The
latter is thought to be due to the gestational decrease in
renal threshold for iodine that favours enhanced urinary
iodine loss. Our results are, therefore, in support of pre-
vious reports that hypothyroidism is a common finding
during pregnancy in areas with sub-optimal iodine
intake [2-4,23-26]. One of the findings of this study is
that the probability of hypothyroidism during pregnancy
has a direct relationship to the gestational age. This is
consistent with other previous reports indicating a simi-
lar relationship [3,25].
Hypothyroidism during pregnancy, even if it is of a
mild degree, is associated with increased risk of fetal
abnormalities [4-7]. However, it is uncertain whether
the high prevalence observed in our initial study also
connotes a high prevalence of fetal abnormalities. This
is because fetal screening was not part of the study
design. Screening for and treating hypothyroidism dur-
ing the neonatal period is routinely done in many devel-
oped countries today [26]. However, routine screening
of pregnant women for hypothyroidism has not yet
become established practice, despite the numerous
experimental data indicating that the adverse fetal con-
sequences of maternal hypothyroidism in pregnancy are
preventable by maternal supplementation with iodine
and/or L-thyroxin [27,28]. This is presumptive of a need
for routine screening for occult hypothyroidism among
pregnant women and for replacement therapy in
affected cases [8].
In addition to the stress occasioned by the increased
thyroxin demand on the maternal thyroid gland, preg-
nancy is also associated with a marked increase in
serum thyroxin-binding globulin (TBG) levels in late
pregnancy as well as an increase in the thyrotrophic
effect of human chorionic gonadotrophin (hCG), espe-
cially in early pregnancy [29]. The gestational increase
in maternal thyroxin demand, coupled with other gesta-
tional metabolic changes, results in profound, compen-
satory alterations in the size and function of the thyroid
gland [23,29,30]. In areas with sub-optimal iodine intake
the observed trend is an increase in maternal basal
serum TSH level and/or a decrease in serum FT4; a
trend that has been shown to increase in intensity with
advancing gestational age up to the time of delivery
[26]. The relative trends in TSH and FT4 values found
in the initial and the validation studies are in keeping
with these observations. High TSH and low FT4 have
been shown to be independent risk factors for the out-
come of pregnancy [31,32]. Besides, the compensatory
morphological changes observed in the maternal thyroid
gland have been shown to persist far into the post-par-
tum period; leading to the widely accepted conclusion
that the thyroidal effect of subsequent pregnancies is a
cumulative aggravation, irrespective of whether they end
up in term delivery or in abortion [33,35]. The latter
may be part of the explanations for the direct relation-
ship found in the current study between the probability
of gestational hypothyroidism and goiter as well as the
gravidity of the women. This fact also informed our pre-
ference of gravidity to parity as a parameter of interest
in the current investigation.
Although clinically overt hypothyroidism may be easily
recognized in pregnant women on the basis of symp-
toms and signs, milder degrees of hypothyroidism may
go unnoticed because affected pregnant women clini-
cally appear healthy. The only way to detect these is by
performing the chemical tests of thyroid function. Che-
mical tests of thyroid function, if used for the routine
screening of all pregnant women living in high-risk
areas for IDD, would certainly be too costly an enter-
prise and, therefore, unaffordable. A search for cheaper
and simpler, yet reliable methods of preliminary screen-
ing for hypothyroidism in pregnancy has, therefore,
become imperative. It is this consideration that has
necessitated the current study, one of the objectives of
which is to examine the possible use of some clinical
parameters in the prediction of clinically occult
hypothyroidism among pregnant women. Although such
a finding, even if confirmed, is unlikely to replace the
biochemical tests of thyroid function it may go a long
way as an initial screening tool in order to save cost.
The statistically significant differences in gestational
age, gravidity, goiter rates and body weight as found
between the hypothyroid and non-hypothyroid pregnant
women in the initial study offered a good opportunity
for the formulation and testing of the afore-stated study
hypothesis. The relationship of these same variables to
the gestational status of thyroid function has been
described in previous, non-Nigerian studies [3,4]. How-
ever, to the best of our knowledge, there has not been
any previous attempt to fit discriminant models to these
clinical data in an attempt to predict the presence or
absence of hypothyroidism during pregnancy. The two
Models developed, Model I (goiter score, gravidity and
gestational age fitted) and Model II (goiter score, gravid-
ity and body weight fitted) both theoretically showed
good performance as evidenced by their high sensitiv-
ities, good specificities and reasonable overall
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kindling of hope for poor countries at risk for IDD,
where facilities for all-inclusive biochemical screening
for hypothyroidism among pregnant women is either
unavailable or unaffordable.
The earliest time that it becomes practicable to screen
pregnant women medically is during the time of book-
ing. It is this understandingt h a ti n f o r m e dt h ef o c u s i n g
of the validation study on subjects who came for book-
ing. The mean gestational age of the women used in the
current validation study is in agreement with what has
been reported previously in the literature among preg-
nant Nigerian women at booking [36-39]. The younger
gestational age of the subjects in the validation study,
compared with those in the initial study, may also partly
explain the significant differences found between the
two groups with respect to the other clinical parameter
values.
The subjects in the prospective validation study, when
compared with those in the initial study, were also
found to have significantly lower TSH and higher FT4
indicative of relative hyperthyroidism. More recently,
longitudinal studies among pregnant women have
widened our understanding of some of the mechanisms
of gestational thyroid function regulation. The first half
of pregnancy is associated with high levels of human
chorionic gonadotrophin (hCG) [40-42] while the sec-
ond half is characterized by high levels of thyroxin-bind-
ing globulin (TBG) [43,44] as well as a reduction in the
renal threshold for iodine which results in its increased
urinary loss [45,46]. That hCG has a thyrotrophic effect
is a well documented fact [29,40] and this may be part
of the explanations for the relative hyperthyroidism in
the validation study compared with what was found in
the initial study. It is possible that differences in the
concentrations of hCG and TBG between the two
groups may help in explaining the parameter differences
observed. It is interesting; however, that despite these
differences Model I and Model II both fitted the valida-
tion data in which both exhibited 100% sensitivity each.
It is uncertain whether or not, and if so to what extent,
this finding may have been influenced by the low preva-
lence rate of hypothyroidism in the validation study.
In conclusion therefore, these results are supportive of
the study hypothesis that models based on clinically
obtainable information can be predictive of maternal
hypothyroidism in pregnancy. If confirmed, such models
could be cost-saving and, therefore, veritable epidemio-
logic tools for maternal thyroid function screening dur-
ing pregnancy; more especially in settings with limited
iodine intake. Although the evidence provided in the
current study appears compelling, it is still far from
being conclusive. One of the considered achievements of
the current exposition is that a new direction of focus
may have been chatted out as grounds for further
research.
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